Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-3882845 also binds to the progesterone receptor (the binding IC50: 310 nM). PF-3882845 is a remarkably high affinity selective and orally efficacious mineralocorticoid receptor (MR binding IC50=2.7 nM) antagonist for hypertension and nephropathy.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | PF-3882845 also binds to the progesterone receptor (the binding IC50: 310 nM). PF-3882845 is a remarkably high affinity selective and orally efficacious mineralocorticoid receptor (MR binding IC50=2.7 nM) antagonist for hypertension and nephropathy. |
Targets&IC50 | Progesterone receptor:310 nM, Mineralocorticoid receptor:2.7 nM |
In vivo | PF-3882845 shows moderate oral bioavailability (F 86%) following oral administration (2 mg/kg) in male Sprague-Dawley rats. PF-3882845 displays terminal elimination half-lives (T1/2 1.7 h) due to high plasma clearance (CL 9.8 mL/min/kg) combined with large volumes of distribution (Vdss 1.4 mL/kg respectively) following intravenous administration (2 mg/kg) in male Sprague-Dawley rats. PF-3882845 decreases blood pressure, decreases urinary albumin, and protects kidney in Dahl SS rat [1]. |
Molecular Weight | 419.9 |
Formula | C24H22ClN3O2 |
CAS No. | 1023650-66-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PF-3882845 1023650-66-9 Others PF3882845 PF 3882845 inhibitor inhibit